Does RANIBIZUMAB Cause Vitreous floaters? 458 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 458 reports of Vitreous floaters have been filed in association with RANIBIZUMAB (CIMERLI). This represents 3.0% of all adverse event reports for RANIBIZUMAB.
458
Reports of Vitreous floaters with RANIBIZUMAB
3.0%
of all RANIBIZUMAB reports
5
Deaths
73
Hospitalizations
How Dangerous Is Vitreous floaters From RANIBIZUMAB?
Of the 458 reports, 5 (1.1%) resulted in death, 73 (15.9%) required hospitalization, and 2 (0.4%) were considered life-threatening.
Is Vitreous floaters Listed in the Official Label?
Yes, Vitreous floaters is listed as a known adverse reaction in the official FDA drug label for RANIBIZUMAB.
What Other Side Effects Does RANIBIZUMAB Cause?
Death (2,250)
Off label use (1,467)
Visual acuity reduced (1,342)
Visual impairment (1,185)
No adverse event (1,012)
Drug ineffective (831)
Blindness (760)
Vision blurred (711)
Eye pain (632)
Cerebrovascular accident (543)
What Other Drugs Cause Vitreous floaters?
AFLIBERCEPT (690)
BROLUCIZUMAB-DBLL (479)
BEVACIZUMAB (323)
ADALIMUMAB (300)
DUPILUMAB (300)
CIPROFLOXACIN (189)
FINGOLIMOD (129)
FARICIMAB\FARICIMAB-SVOA (123)
UPADACITINIB (112)
LEVOFLOXACIN (93)
Which RANIBIZUMAB Alternatives Have Lower Vitreous floaters Risk?
RANIBIZUMAB vs RANIMUSTINE
RANIBIZUMAB vs RANITIDINE
RANIBIZUMAB vs RANITIDINE\RANITIDINE
RANIBIZUMAB vs RANOLAZINE
RANIBIZUMAB vs RAPAMUNE